Associate Professor
Dana Farber Cancer Institute
Dr. Rachel Freedman is a medical oncologist specializing in breast cancer at Dana-Farber Cancer Institute, Assistant Professor of Medicine at Harvard Medical School, and Medical Director of the Dana-Farber Cancer Care Collaborative. Her clinical research primarily focuses on the care of vulnerable patients populations who are not well represented in clinical trials to date and who suffer from worse outcomes once they are diagnosed with breast cancer. Her research has included large scale database and registry-based studies, qualitative work, survey studies, and interventions targeted towards improving the evidence base and outcomes for women at risk for poor outcomes. She is the Principal Investigator of multiple multicenter clinical trials, primarily targeting populations not well represented in research.
Dr. Freedman is a graduate of Georgetown University School of Medicine. She completed her residency at Beth Israel Medical Center (Boston, MA, USA) and her medical oncology fellowship at Dana-Farber Cancer Institute (Boston, MA, USA). She received a Master in Public Health from Harvard University’s School of Public Health and has been on faculty at Dana-Farber since 2009. Her work has been funded by multiple organizations such as Susan G. Komen, the American Cancer Society, the National Cancer Institute, Gateway for Cancer Research and the Alliance for Clinical Trials in Oncology.